LIST OF CONTROLLED MEDICATION FOR DOGS As of February 8th 2013
1. Antibiotics administered orally. A Veterinary Form 1, Medication
Administration Form must be filled out by the treating veterinarian to indicate medication, dosage, and reason for treating. If antibiotic treatment must be initiated on a dog prior to an event, the form should be filled out by the attending veterinarian, and the athlete must bring the form to the race and submit it to the Race Veterinarian prior to the event, at the veterinary check of the dogs or the first team meeting. Upon review of the form and examination of the dog, the Race Veterinarian has the right to prevent the dog from competing depending on the medical condition of the dog. It is recommended that the athlete contact the Race Veterinarian in advance of the event.
2. Topical eye, foot, or wound ointments or drops containing antibiotics will be allowed with completion and submission of a Veterinary Form 1 (Medication Administration Form) and evaluation of the dog by the Race Veterinarian. Topical eye or foot medications containing low levels of corticosteroids may be allowed for specific medical reasons, and require completion and submission of Veterinary Form 1, and evaluation of the dog by the Race Veterinarian.
3. Antiulcer medications – H2 antagonists and proton pump inhibitors will
be allowed with completion and submission of a Veterinary Form 1 (Medication Administration Form).
4. Thyroid hormone supplements may be given orally if a Veterinary Form
2, Authorization for administration of Thyroid Supplements is filled out and has supportive laboratory blood tests accompanying it. Supplements will NOT be allowed for low normal levels. Test results must be interpreted using the normal values for sled dogs listed on the Veterinary Form 2. These values are different than standard laboratory values. Post- supplementation blood tests must show that the dog is given an appropriate dosage, not over supplemented, and does not have a high level post- supplement using the sled dog values.
5. Reproductive hormones, related substances, and their releasing factors,
antagonists, modulators and related substances as listed below
a. treatments to continually suppress or delay the onset of heat
cycles in bitches, under veterinary prescription, unless such
treatments contain testosterone or testosterone-like substances
(see WADA human Prohibited List). The athlete must be able to
show a Medication Administration Form, including the dog’s chip
number, covering the treatment from start.
b. The administration to bitches of prostaglandins or progesterone
inhibitors such as aglepriston, under veterinary prescription, will be
tolerated if required due to an accidental mating. However, a minimum
IFSS Controlled medication list Feb. 08, 2013
observation period of 28 days, before the bitch returns to competition,
will be mandatory in order to ensure that there are no adverse side
effects on the bitch’s health. The athlete must, at any time, be able to
show a Medication Administration Form, including the dog’s chip
c. The administration of bromocriptine or cabergoline to suppress
lactation in a bitch will be allowed. However, a minimum observation
period of 28 days, before the bitch returns to competition, will be
mandatory in order to ensure that there are no adverse side effects on
the bitch’s health. The athlete must, at any time, be able to show a
Medication Administration Form, including the dog’s chip number,
d. The use of deslorelin implants in intact males or intact females for
the purpose of contraception will be allowed. The athlete must, at any
time, be able to show a Medication Administration Form, including the
dog’s chip number covering the treatment.
e. The administration to spayed bitches of estrogenic substances under
veterinary prescription if required to avoid urinary incontinence. The
athlete must, at any time, be able to show a Medication Administration
Form, including the dog’s chip number, about this need of treatment.
IFSS Controlled medication list Feb. 08, 2013
T h e n e w e n g l a n d j o u r n a l o f m e d i c i n e This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author’s clinical recommendations. A 66-year-old woman who is overweight reports bilate
Life Extension Newsletter, November 11, 2004 In this issue Life Extension Update Exclusive: Adding psyllium to simvastatin as effective as doubling dose Protocol: Featured Products: Life Extension magazine November 2004 issue: Novel Dietary Supplement Shows Dramatic Effects in Lowering Cholesterol, LDL, and Risk free: You may unsubscribe at any